[1] LI DJ,SHI J,JIN J,et al.Epidemiological trend of cervical cancer[J].Chin J Oncol,2021,43(9):912-916.
[2] SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[3] EUN TJ,PERKINS RB.Screening for cervical cancer[J].Med Clin North Am,2020,104(6):1063-1078.
[4] WANG R,PAN W,JIN L,et al.Human papillomavirus vaccine against cervical cancer:Opportunity and challenge[J].Cancer Lett,2020,471(2):88-102.
[5] FANG Y,FULLWOOD MJ.Roles,functions,and mechanisms of long non-coding RNAs in cancer[J].Genomics Proteomics Bioinformatics,2016,14(1):42-54.
[6] XING C,SUN SG,YUE ZQ,et al.Role of lncRNA LUCAT1 in cancer[J].Biomed Pharmacother,2021,134(2):1-10.
[7] ZHAO Y,SUN H,WANG H.Long noncoding RNAs in DNA methylation:new players stepping into the old game[J].Cell Biosci,2016,6(7):45-51.
[8] O' LEARY VB,HAIN S,MAUGG D,et al.Long non-coding RNA PARTICLE bridges histone and DNA methylation[J].Sci Rep,2017,7(1):1-12.
[9] HAN P,CHANG CP.Long non-coding RNA and chromatin remodeling[J].RNA Biol,2015,12(10):1094-1098.
[10]YOON JH,ABDELMOHSEN K,GOROSPE M.Functional interactions among microRNAs and long noncoding RNAs[J].Semin Cell Dev Biol,2014,34(10):9-14.
[11]SHENG H,ZHANG J,MA Y,et al.lncRNA FBXL19-AS1 is a diagnosis biomarker for paediatric patients with acute myeloid leukemia[J].J Gene Med,2021,23(3):1-6.
[12] HUANG X,SHI H,SHI X,et al.LncRNA FBXL19-AS1 promotes proliferation and metastasis of cervical cancer through upregulating COL1A1 as a sponge of miR-193a-5p[J].J Biol Res (Thessalon),2021,28(1):20-34.
[13] YANG X,XIE Z,LEI X,et al.Long non-coding RNA GAS5 in human cancer[J].Oncol Lett,2020,20(3):2587-2594.
[14] POLLMANN MARC,PARWARESCH REZA,ADAM-KLAGES SABINE,et al.Human EML4,a novel member of the EMAP family,is essential for microtubule formation[J].Exp Cell Res,2006,312(17):3241-3251.
[15] TAKEUCHI K,SODA M,TOGASHI Y,et al.RET,ROS1 and ALK fusions in lung cancer[J].Nature Medicine,2012,18(3):378-381.
[16] KARIMI ZARCHI M,BEHTASH N,CHITI Z,et al.Cervical cancer and HPV vaccines in developing countries[J].Asian Pac J Cancer Prev,2009,10(6):969-974.
[17] YUAN Y,CAI X,SHEN F,et al.HPV post-infection microenvironment and cervical cancer[J].Cancer Lett,2021,497(1):243-254.
[18] MARTIN CM,KEHOE L,SPILLANE CO,et al.Gene discovery in cervical cancer:towards diagnostic and therapeutic biomarkers[J].Mol Diagn Ther,2007,11(5):277-290.
[19] LUAN Y,XIE B,WEI W.REST-repressed lncRNA NPPA-AS1 regulates cervical cancer progression by modulating miR-302e/DKK1/Wnt/β-catenin signaling pathway[J].J Cell Biochem,2021,122(1):16-28.
[20]NIKPAYAM E,TASHARROFI B,SARRAFZADEH S,et al.The role of long non-coding RNAs in ovarian cancer[J].Iran Biomed J,2017,21(1):3-15.
[21] TORNESELLO ML,FARAONIO R,BUONAGURO L,et al.The role of microRNAs,long non-coding RNAs,and circular RNAs in cervical cancer[J].Front Oncol,2020,10(2):1-16.
[22] SCHMITT AM,CHANG HY.Long noncoding RNAs in cancer pathways[J].Cancer Cell,2016,29(4):452-463.
[23] FATICA A,BOZZONI I.Long non-coding RNAs:new players in cell differentiation and development[J].Nat Rev Genet,2014,15(1):7-21.
[24] HU YL,ZHANG YX,LIU N,et al.LncRNA MIR503HG regulated cell viability,metastasis and apoptosis of cervical cancer via miR-191/CEBPB axis[J].Eur Rev Med Pharmacol Sci,2021,25(8):3200-3210.